Lefamulin acetate
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-16908A-10 mg |
| CAS # | 1350636-82-6 |
| Pricing | 10 mg, USD $550.0 |
| Synonyms | BC-3781 acetate |
| MWt | 567.78 |
| Formula | C₃₀H₄₉NO₇S |
| Biological Activity | Lefamulin acetate (BC-3781 acetate) is an orally active antibiotic for community-acquired bacterial pneumonia (CABP) treatment. Lefamulin acetate (BC-3781 acetate) is the first semi-synthetic pleuromutilin for systemic treatment of bacterial infections in humans. Lefamulin acetate (BC-3781 acetate) inhibits protein synthesis by binding to the peptidyl transferase center of the 50S bacterial ribosome, preventing the binding of transfer RNA for peptide transfer[1]. |
| Purity | 98.02% |